APO Research

APO RESEARCH · REPORT

Microarray Services

Selected research

Market Analysis & Forecast

Global Microarray Services Market Analysis and Forecast 2026-2032

Market perspective

The global Microarray Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Microarray Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Microarray Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Microarray Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Microarray Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Microarray Services include Merck, Thermo Fisher Scientific, SCHOTT, Psomagen, PerkinElmer, OGT, Molecular Devices, LC Sciences and Illumina, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Microarray Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Microarray Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Microarray Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Microarray Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Microarray Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Microarray Services revenue, projected growth trends, production technology, application and end-user industry.

Microarray Services Segment by Company

Merck

Thermo Fisher Scientific

SCHOTT

Psomagen

PerkinElmer

OGT

Molecular Devices

LC Sciences

Illumina

Hokkaido System Science

GE Healthcare

Creative Biolabs

CD Genomics

Bio-Rad Laboratories

Bionexus

Arrayit

Agilent

Affymetrix

Microarray Services Segment by Type

Gene Expression Microarray

Genotyping Microarray

Methylation Microarray

Transcriptome Microarray

Microarray Services Segment by Application

Drug Development

Medical Research

Others

Microarray Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microarray Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microarray Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microarray Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Microarray Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Microarray Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Microarray Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Microarray Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Gene Expression Microarray Major Player Table 3. Genotyping Microarray Major Player Table 4. Methylation Microarray Major Player Table 5. Transcriptome Microarray Major Player Table 6. Global Microarray Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Drug Development Major Player Table 8. Medical Research Major Player Table 9. Others Major Player Table 10. Microarray Services Industry Trends Table 11. Microarray Services Industry Drivers Table 12. Microarray Services Industry Opportunities and Challenges Table 13. Microarray Services Industry Restraints Table 14. Global Microarray Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Microarray Services Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Microarray Services Market Share by Region (2021-2026) Table 17. Global Microarray Services Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Microarray Services Market Share by Region (2027-2032) Table 19. Global Microarray Services Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Microarray Services Revenue Market Share by Players (2021-2026) Table 21. Global Microarray Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Microarray Services Key Players Headquarters & Area Served Table 23. Global Microarray Services Players, Product Type & Application Table 24. Global Microarray Services Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Microarray Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Microarray Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Microarray Services Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Microarray Services Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Microarray Services Revenue Market Share by Type (2021-2026) Table 31. Global Microarray Services Revenue Market Share by Type (2027-2032) Table 32. Global Microarray Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Microarray Services Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Microarray Services Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Microarray Services Revenue Market Share by Application (2021-2026) Table 36. Global Microarray Services Revenue Market Share by Application (2027-2032) Table 37. Merck Company Information Table 38. Merck Business Overview Table 39. Merck Microarray Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Merck Microarray Services Product Portfolio Table 41. Merck Recent Development Table 42. Thermo Fisher Scientific Company Information Table 43. Thermo Fisher Scientific Business Overview Table 44. Thermo Fisher Scientific Microarray Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Thermo Fisher Scientific Microarray Services Product Portfolio Table 46. Thermo Fisher Scientific Recent Development Table 47. SCHOTT Company Information Table 48. SCHOTT Business Overview Table 49. SCHOTT Microarray Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. SCHOTT Microarray Services Product Portfolio Table 51. SCHOTT Recent Development Table 52. Psomagen Company Information Table 53. Psomagen Business Overview Table 54. Psomagen Microarray Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Psomagen Microarray Services Product Portfolio Table 56. Psomagen Recent Development Table 57. PerkinElmer Company Information Table 58. PerkinElmer Business Overview Table 59. PerkinElmer Microarray Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. PerkinElmer Microarray Services Product Portfolio Table 61. PerkinElmer Recent Development Table 62. OGT Company Information Table 63. OGT Business Overview Table 64. OGT Microarray Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. OGT Microarray Services Product Portfolio Table 66. OGT Recent Development Table 67. Molecular Devices Company Information Table 68. Molecular Devices Business Overview Table 69. Molecular Devices Microarray Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Molecular Devices Microarray Services Product Portfolio Table 71. Molecular Devices Recent Development Table 72. LC Sciences Company Information Table 73. LC Sciences Business Overview Table 74. LC Sciences Microarray Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. LC Sciences Microarray Services Product Portfolio Table 76. LC Sciences Recent Development Table 77. Illumina Company Information Table 78. Illumina Business Overview Table 79. Illumina Microarray Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Illumina Microarray Services Product Portfolio Table 81. Illumina Recent Development Table 82. Hokkaido System Science Company Information Table 83. Hokkaido System Science Business Overview Table 84. Hokkaido System Science Microarray Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Hokkaido System Science Microarray Services Product Portfolio Table 86. Hokkaido System Science Recent Development Table 87. GE Healthcare Company Information Table 88. GE Healthcare Business Overview Table 89. GE Healthcare Microarray Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. GE Healthcare Microarray Services Product Portfolio Table 91. GE Healthcare Recent Development Table 92. Creative Biolabs Company Information Table 93. Creative Biolabs Business Overview Table 94. Creative Biolabs Microarray Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Creative Biolabs Microarray Services Product Portfolio Table 96. Creative Biolabs Recent Development Table 97. CD Genomics Company Information Table 98. CD Genomics Business Overview Table 99. CD Genomics Microarray Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. CD Genomics Microarray Services Product Portfolio Table 101. CD Genomics Recent Development Table 102. Bio-Rad Laboratories Company Information Table 103. Bio-Rad Laboratories Business Overview Table 104. Bio-Rad Laboratories Microarray Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Bio-Rad Laboratories Microarray Services Product Portfolio Table 106. Bio-Rad Laboratories Recent Development Table 107. Bionexus Company Information Table 108. Bionexus Business Overview Table 109. Bionexus Microarray Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Bionexus Microarray Services Product Portfolio Table 111. Bionexus Recent Development Table 112. Arrayit Company Information Table 113. Arrayit Business Overview Table 114. Arrayit Microarray Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Arrayit Microarray Services Product Portfolio Table 116. Arrayit Recent Development Table 117. Agilent Company Information Table 118. Agilent Business Overview Table 119. Agilent Microarray Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Agilent Microarray Services Product Portfolio Table 121. Agilent Recent Development Table 122. Affymetrix Company Information Table 123. Affymetrix Business Overview Table 124. Affymetrix Microarray Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Affymetrix Microarray Services Product Portfolio Table 126. Affymetrix Recent Development Table 127. North America Microarray Services Revenue by Type (2021-2026) & (US$ Million) Table 128. North America Microarray Services Revenue by Type (2027-2032) & (US$ Million) Table 129. North America Microarray Services Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Microarray Services Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Microarray Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. North America Microarray Services Revenue by Country (2021-2026) & (US$ Million) Table 133. North America Microarray Services Revenue by Country (US$ Million) & (2027-2032) Table 134. Europe Microarray Services Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe Microarray Services Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe Microarray Services Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe Microarray Services Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe Microarray Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Microarray Services Revenue by Country (2021-2026) & (US$ Million) Table 140. Europe Microarray Services Revenue by Country (US$ Million) & (2027-2032) Table 141. China Microarray Services Revenue by Type (2021-2026) & (US$ Million) Table 142. China Microarray Services Revenue by Type (2027-2032) & (US$ Million) Table 143. China Microarray Services Revenue by Application (2021-2026) & (US$ Million) Table 144. China Microarray Services Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Microarray Services Revenue by Type (2021-2026) & (US$ Million) Table 146. Asia Microarray Services Revenue by Type (2027-2032) & (US$ Million) Table 147. Asia Microarray Services Revenue by Application (2021-2026) & (US$ Million) Table 148. Asia Microarray Services Revenue by Application (2027-2032) & (US$ Million) Table 149. Asia Microarray Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia Microarray Services Revenue by Region (US$ Million) & (2021-2026) Table 151. Asia Microarray Services Revenue by Region (US$ Million) & (2027-2032) Table 152. SAMEA Microarray Services Revenue by Type (2021-2026) & (US$ Million) Table 153. SAMEA Microarray Services Revenue by Type (2027-2032) & (US$ Million) Table 154. SAMEA Microarray Services Revenue by Application (2021-2026) & (US$ Million) Table 155. SAMEA Microarray Services Revenue by Application (2027-2032) & (US$ Million) Table 156. SAMEA Microarray Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. SAMEA Microarray Services Revenue by Country (2021-2026) & (US$ Million) Table 158. SAMEA Microarray Services Revenue by Country (US$ Million) & (2027-2032) Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Microarray Services Image Figure 2. Global Microarray Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microarray Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Gene Expression Microarray Image Figure 5. Genotyping Microarray Image Figure 6. Methylation Microarray Image Figure 7. Transcriptome Microarray Image Figure 8. Global Microarray Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Microarray Services Market Size Share 2021 VS 2025 VS 2032 Figure 10. Drug Development Image Figure 11. Medical Research Image Figure 12. Others Image Figure 13. Global Microarray Services Market Size (US$ Million) & (2021-2032) Figure 14. Global Microarray Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Microarray Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Microarray Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Microarray Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Microarray Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Microarray Services Revenue Market Share by Type (2021-2032) Figure 21. Global Microarray Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Microarray Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Microarray Services Revenue Market Share by Application (2021-2032) Figure 24. North America Microarray Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Microarray Services Revenue Share by Type (2021-2032) Figure 26. North America Microarray Services Revenue Share by Application (2021-2032) Figure 27. North America Microarray Services Revenue Share by Country (2021-2032) Figure 28. United States Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Microarray Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Microarray Services Revenue Share by Type (2021-2032) Figure 33. Europe Microarray Services Revenue Share by Application (2021-2032) Figure 34. Europe Microarray Services Revenue Share by Country (2021-2032) Figure 35. Germany Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Microarray Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Microarray Services Revenue Share by Type (2021-2032) Figure 45. China Microarray Services Revenue Share by Application (2021-2032) Figure 46. Asia Microarray Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Microarray Services Revenue Share by Type (2021-2032) Figure 48. Asia Microarray Services Revenue Share by Application (2021-2032) Figure 49. Asia Microarray Services Revenue Share by Region (2021-2032) Figure 50. Japan Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Microarray Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Microarray Services Revenue Share by Type (2021-2032) Figure 58. SAMEA Microarray Services Revenue Share by Application (2021-2032) Figure 59. SAMEA Microarray Services Revenue Share by Country (2021-2032) Figure 60. Brazil Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Microarray Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Gene Expression Microarray
  • Genotyping Microarray
  • Methylation Microarray
  • Transcriptome Microarray
Applications
  • Drug Development
  • Medical Research
  • Others
Companies covered
  • Merck
  • Thermo Fisher Scientific
  • SCHOTT
  • Psomagen
  • PerkinElmer
  • OGT
  • Molecular Devices
  • LC Sciences
  • Illumina
  • Hokkaido System Science
  • GE Healthcare
  • Creative Biolabs
  • CD Genomics
  • Bio-Rad Laboratories
  • Bionexus
  • Arrayit
  • Agilent
  • Affymetrix

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Microarray Services Market by Type
  3. 1.2.1 Global Microarray Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Gene Expression Microarray
  5. 1.2.3 Genotyping Microarray
  6. 1.2.4 Methylation Microarray
  7. 1.2.5 Transcriptome Microarray
  8. 1.3 Microarray Services Market by Application
  9. 1.3.1 Global Microarray Services Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Drug Development
  11. 1.3.3 Medical Research
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Microarray Services Market Dynamics
  1. 2.1 Microarray Services Industry Trends
  2. 2.2 Microarray Services Industry Drivers
  3. 2.3 Microarray Services Industry Opportunities and Challenges
  4. 2.4 Microarray Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Microarray Services Market Perspective (2021-2032)
  2. 3.2 Global Microarray Services Growth Trends by Region
  3. 3.2.1 Global Microarray Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Microarray Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Microarray Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Microarray Services Revenue by Players
  2. 4.1.1 Global Microarray Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Microarray Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Microarray Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Microarray Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Microarray Services Key Players Headquarters & Area Served
  7. 4.4 Global Microarray Services Players, Product Type & Application
  8. 4.5 Global Microarray Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Microarray Services Market CR5 and HHI
  11. 4.6.3 2025 Microarray Services Tier 1, Tier 2, and Tier 3
5 Microarray Services Market Size by Type
  1. 5.1 Global Microarray Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Microarray Services Revenue by Type (2021-2032)
  3. 5.3 Global Microarray Services Revenue Market Share by Type (2021-2032)
6 Microarray Services Market Size by Application
  1. 6.1 Global Microarray Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Microarray Services Revenue by Application (2021-2032)
  3. 6.3 Global Microarray Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Microarray Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Merck Microarray Services Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Thermo Fisher Scientific
  8. 7.2.1 Thermo Fisher Scientific Company Information
  9. 7.2.2 Thermo Fisher Scientific Business Overview
  10. 7.2.3 Thermo Fisher Scientific Microarray Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Thermo Fisher Scientific Microarray Services Product Portfolio
  12. 7.2.5 Thermo Fisher Scientific Recent Developments
  13. 7.3 SCHOTT
  14. 7.3.1 SCHOTT Company Information
  15. 7.3.2 SCHOTT Business Overview
  16. 7.3.3 SCHOTT Microarray Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 SCHOTT Microarray Services Product Portfolio
  18. 7.3.5 SCHOTT Recent Developments
  19. 7.4 Psomagen
  20. 7.4.1 Psomagen Company Information
  21. 7.4.2 Psomagen Business Overview
  22. 7.4.3 Psomagen Microarray Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Psomagen Microarray Services Product Portfolio
  24. 7.4.5 Psomagen Recent Developments
  25. 7.5 PerkinElmer
  26. 7.5.1 PerkinElmer Company Information
  27. 7.5.2 PerkinElmer Business Overview
  28. 7.5.3 PerkinElmer Microarray Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 PerkinElmer Microarray Services Product Portfolio
  30. 7.5.5 PerkinElmer Recent Developments
  31. 7.6 OGT
  32. 7.6.1 OGT Company Information
  33. 7.6.2 OGT Business Overview
  34. 7.6.3 OGT Microarray Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 OGT Microarray Services Product Portfolio
  36. 7.6.5 OGT Recent Developments
  37. 7.7 Molecular Devices
  38. 7.7.1 Molecular Devices Company Information
  39. 7.7.2 Molecular Devices Business Overview
  40. 7.7.3 Molecular Devices Microarray Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Molecular Devices Microarray Services Product Portfolio
  42. 7.7.5 Molecular Devices Recent Developments
  43. 7.8 LC Sciences
  44. 7.8.1 LC Sciences Company Information
  45. 7.8.2 LC Sciences Business Overview
  46. 7.8.3 LC Sciences Microarray Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 LC Sciences Microarray Services Product Portfolio
  48. 7.8.5 LC Sciences Recent Developments
  49. 7.9 Illumina
  50. 7.9.1 Illumina Company Information
  51. 7.9.2 Illumina Business Overview
  52. 7.9.3 Illumina Microarray Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Illumina Microarray Services Product Portfolio
  54. 7.9.5 Illumina Recent Developments
  55. 7.10 Hokkaido System Science
  56. 7.10.1 Hokkaido System Science Company Information
  57. 7.10.2 Hokkaido System Science Business Overview
  58. 7.10.3 Hokkaido System Science Microarray Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Hokkaido System Science Microarray Services Product Portfolio
  60. 7.10.5 Hokkaido System Science Recent Developments
  61. 7.11 GE Healthcare
  62. 7.11.1 GE Healthcare Company Information
  63. 7.11.2 GE Healthcare Business Overview
  64. 7.11.3 GE Healthcare Microarray Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 GE Healthcare Microarray Services Product Portfolio
  66. 7.11.5 GE Healthcare Recent Developments
  67. 7.12 Creative Biolabs
  68. 7.12.1 Creative Biolabs Company Information
  69. 7.12.2 Creative Biolabs Business Overview
  70. 7.12.3 Creative Biolabs Microarray Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Creative Biolabs Microarray Services Product Portfolio
  72. 7.12.5 Creative Biolabs Recent Developments
  73. 7.13 CD Genomics
  74. 7.13.1 CD Genomics Company Information
  75. 7.13.2 CD Genomics Business Overview
  76. 7.13.3 CD Genomics Microarray Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 CD Genomics Microarray Services Product Portfolio
  78. 7.13.5 CD Genomics Recent Developments
  79. 7.14 Bio-Rad Laboratories
  80. 7.14.1 Bio-Rad Laboratories Company Information
  81. 7.14.2 Bio-Rad Laboratories Business Overview
  82. 7.14.3 Bio-Rad Laboratories Microarray Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Bio-Rad Laboratories Microarray Services Product Portfolio
  84. 7.14.5 Bio-Rad Laboratories Recent Developments
  85. 7.15 Bionexus
  86. 7.15.1 Bionexus Company Information
  87. 7.15.2 Bionexus Business Overview
  88. 7.15.3 Bionexus Microarray Services Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Bionexus Microarray Services Product Portfolio
  90. 7.15.5 Bionexus Recent Developments
  91. 7.16 Arrayit
  92. 7.16.1 Arrayit Company Information
  93. 7.16.2 Arrayit Business Overview
  94. 7.16.3 Arrayit Microarray Services Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Arrayit Microarray Services Product Portfolio
  96. 7.16.5 Arrayit Recent Developments
  97. 7.17 Agilent
  98. 7.17.1 Agilent Company Information
  99. 7.17.2 Agilent Business Overview
  100. 7.17.3 Agilent Microarray Services Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Agilent Microarray Services Product Portfolio
  102. 7.17.5 Agilent Recent Developments
  103. 7.18 Affymetrix
  104. 7.18.1 Affymetrix Company Information
  105. 7.18.2 Affymetrix Business Overview
  106. 7.18.3 Affymetrix Microarray Services Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Affymetrix Microarray Services Product Portfolio
  108. 7.18.5 Affymetrix Recent Developments
8 North America
  1. 8.1 North America Microarray Services Revenue (2021-2032)
  2. 8.2 North America Microarray Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Microarray Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Microarray Services Revenue by Type (2027-2032)
  5. 8.3 North America Microarray Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Microarray Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Microarray Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Microarray Services Revenue by Application (2027-2032)
  9. 8.5 North America Microarray Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Microarray Services Revenue by Country
  11. 8.6.1 North America Microarray Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Microarray Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Microarray Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Microarray Services Revenue (2021-2032)
  2. 9.2 Europe Microarray Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Microarray Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Microarray Services Revenue by Type (2027-2032)
  5. 9.3 Europe Microarray Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Microarray Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Microarray Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Microarray Services Revenue by Application (2027-2032)
  9. 9.5 Europe Microarray Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Microarray Services Revenue by Country
  11. 9.6.1 Europe Microarray Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Microarray Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Microarray Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Microarray Services Revenue (2021-2032)
  2. 10.2 China Microarray Services Revenue by Type (2021-2032)
  3. 10.2.1 China Microarray Services Revenue by Type (2021-2026)
  4. 10.2.2 China Microarray Services Revenue by Type (2027-2032)
  5. 10.3 China Microarray Services Revenue Share by Type (2021-2032)
  6. 10.4 China Microarray Services Revenue by Application (2021-2032)
  7. 10.4.1 China Microarray Services Revenue by Application (2021-2026)
  8. 10.4.2 China Microarray Services Revenue by Application (2027-2032)
  9. 10.5 China Microarray Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Microarray Services Revenue (2021-2032)
  2. 11.2 Asia Microarray Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Microarray Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Microarray Services Revenue by Type (2027-2032)
  5. 11.3 Asia Microarray Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Microarray Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Microarray Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Microarray Services Revenue by Application (2027-2032)
  9. 11.5 Asia Microarray Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Microarray Services Revenue by Country
  11. 11.6.1 Asia Microarray Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Microarray Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Microarray Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Microarray Services Revenue (2021-2032)
  2. 12.2 SAMEA Microarray Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Microarray Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Microarray Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Microarray Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Microarray Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Microarray Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Microarray Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Microarray Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Microarray Services Revenue by Country
  11. 12.6.1 SAMEA Microarray Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Microarray Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Microarray Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research